-
Psychedelic Medicine: 5-MeO-DMT Formula For Treatment-Resistant Depression Has Positive Trial Results
Monday, December 6, 2021 - 3:16pm | 838Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ: GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy candidate for patients suffering from treatment-resistant depression (TRD). The Ireland-based company, which this year announced...
-
Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying
Tuesday, November 16, 2021 - 4:54pm | 563Besides being one of the most intimidating human beings ever to step into the boxing ring, former heavyweight champion Mike Tyson is also in the process of becoming a master at the art of dying. He’s had years of training to get there—as well as the help of a creature called the Sonoran...
-
Psychedelic Compound 5-MeO-DMT Could Make Therapy Short And Effective: Beckley Psytech Is 'All In'
Friday, June 11, 2021 - 10:09am | 12365-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is giving hope to researchers and executives in the psychedelics space who are seeking ...
-
Psyched: California Psychedelics Bill Passes Second Committee, GH Research Closes $125M Series B, Study Shows Psilocybin Could Equal SSRI Results In Depression
Monday, April 19, 2021 - 5:50pm | 1048A bill that would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychedelics in California passed the state Senate Health Committee. The bill will now be reviewed by the Senate Appropriations Committee, after which it would move to a...
-
Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public
Friday, January 1, 2021 - 11:49am | 876The Psychedelics Sector Might Soon Get Its First ETF Financial services company Horizons ETFs Management filed documents with the Ontario Securities Commission for a psychedelics ETF, which is expected to go live on Jan. 15. The ‘Horizons Psychedelic Stock Index ETF’ would become the...
-
Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia
Monday, December 14, 2020 - 11:09am | 892Canada Allows Professionals In Training To Use Psilocybin The Canadian Health Minister Patty Hajdu has allowed 17 healthcare professionals to possess and use psilocybin to conduct professional training in psilocybin-assisted therapy. The decision, announced Tuesday, marks the latest step in Canada...